date,title,source
Oct-22-18,ESMO 2018: Athenex Presented Encouraging Clinical Trial Efficacy and Safety Results of Oraxol in the Treatment of Metastatic Breast Cancer,GlobeNewswire
Oct-26-18,"Recent Analysis Shows Prologis, Delek Logistics Partners, Fabrinet, New York Mortgage Trust, Petroleo Brasileiro S.A.- Petrobras, and Athenex Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Oct-29-18,Athenex Announces FDA Allowance of Investigational New Drug Application of Eribulin ORA to Begin Clinical Trials,GlobeNewswire
Nov-01-18,"Athenex, Inc. to Report Third Quarter Earnings Results on November 14, 2018",GlobeNewswire
Nov-14-18,"Athenex Inc (ATNX) CEO and Chairman of the Board Johnson Yiu Nam Lau Bought $418,800 of Shares",GuruFocus.com
Nov-14-18,Edited Transcript of ATNX earnings conference call or presentation 14-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-14-18,Athenex: 3Q Earnings Snapshot,Associated Press
Nov-14-18,"Athenex, Inc. Announces Third Quarter 2018 Financial Results and Provides Corporate Update",GlobeNewswire
Nov-19-18,"Athenex Inc (ATNX) CEO and Chairman of the Board Johnson Yiu Nam Lau Bought $117,500 of Shares",GuruFocus.com
Nov-26-18,Athenex Announces Initiation of a Phase I/II Clinical Study of Oraxol in Combination with Anti-PD1,GlobeNewswire
Nov-29-18,Athenex Announces Licensing Agreement with PharmaEssentia for Rights to Oradoxel (Oral Docetaxel) in Certain Asian Territories,GlobeNewswire
Dec-06-18,"Recent Analysis Shows Athenex, National CineMedia, Macy's, Manulife Financial, CBS, and Strategic Education Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Dec-06-18,Athenex to Host an R&D Day on December 17 in New York,GlobeNewswire
Dec-11-18,CORRECTION: Athenex Announces Positive Second Cohort Results of Oraxol-plus-Ramucirumab Phase 1b Clinical Trial in Gastric Cancer,GlobeNewswire
Dec-11-18,Athenex Announces Positive Second Cohort Results of Oraxol-plus-Ramucirumab Phase 1b Clinical Trial in Gastric Cancer,GlobeNewswire
Dec-13-18,"Company News For Dec 13, 2018",Zacks
Dec-20-18,"What Kind Of Shareholders Own Athenex, Inc. (NASDAQ:ATNX)?",Simply Wall St.
Dec-26-18,"Athenex Pharmaceutical Division, an Athenex, Inc. Company, Launches Levothyroxine Sodium for Injection",GlobeNewswire
Jan-03-19,Chongqing Jingdong Pharmaceutical and Athenex Announce a Strategic Partnership and Licensing Agreement to Develop and Commercialize KX2-391 in China,GlobeNewswire
Jan-04-19,Teresa Bair talks about the big year ahead for Athenex,American City Business Journals
Jan-09-19,Athenex Announces Completion of Target Enrollment in the Oraxol Phase III Study,GlobeNewswire
Jan-10-19,Athenex Completes Enrollment Target for Breast Cancer Study,Zacks
Jan-10-19,Buffalo startups surpassed $200 million in VC and angel funding in 2018,American City Business Journals
Jan-16-19,Kitov Pharma's Stock Up on Anti-Cancer Candidate Findings,Zacks
Feb-04-19,Athenex Announces Late-Breaking Oral Presentation of KX2-391 Ointment in Two Phase III Studies at the American Academy of Dermatology Annual Meeting,GlobeNewswire
Feb-14-19,"Athenex, Inc. to Report Fourth Quarter and Fiscal Year 2018 Earnings Results on March 11, 2019",GlobeNewswire
Feb-25-19,"New Research Coverage Highlights The Wendy's, Rite Aid, Invesco, LendingClub, Diodes, and Athenex  Consolidated Revenues, Company Growth, and Expectations for 2019",GlobeNewswire
Feb-25-19,Athenex to Host Conference Call with Key Opinion Leader Following Oral Presentation of Phase III Results of KX2-391 Ointment in the Treatment of Actinic Keratosis at the American Academy of Dermatology Annual Meeting,GlobeNewswire
Mar-04-19,Almirall and Athenex Announce Positive Topline Results from Two Phase III Studies of KX2-391 Ointment 1% Featured in Late Breaker Program at the 2019 American Academy of Dermatology Annual Meeting,PR Newswire
Mar-04-19,Shares of Athenex up 3.8% after Phase 3 studies for actinic keratosis treatment meet primary endpoints,MarketWatch
Mar-04-19,Athenex Announces Positive Topline Results from Two Phase III Studies of KX2-391 Ointment 1% Featured in Late Breaker Program at the 2019 American Academy of Dermatology Annual Meeting,GlobeNewswire
Mar-07-19,Athenex Regains Rights to KX2-391 in China,GlobeNewswire
Mar-08-19,Athenex to Present Preclinical Data of Oraxol in the Treatment of Angiosarcoma at the American Association for Cancer Research Annual Meeting 2019,GlobeNewswire
Mar-11-19,"Athenex, Inc. (ATNX) Q4 2018 Earnings Conference Call Transcript",Motley Fool
Mar-11-19,Edited Transcript of ATNX earnings conference call or presentation 11-Mar-19 12:30pm GMT,Thomson Reuters StreetEvents
Mar-11-19,Athenex: 4Q Earnings Snapshot,Associated Press
Mar-11-19,"Athenex, Inc. Announces Fourth Quarter and Year Ended December 31, 2018 Financial Results and Provides Corporate Update",GlobeNewswire
Mar-12-19,Edited Transcript of ATNX earnings conference call or presentation 11-Mar-19 12:30pm GMT,Thomson Reuters StreetEvents
Mar-13-19,The moment Athenex executives and investors have been waiting for is almost here,American City Business Journals
Mar-13-19,SunGen Pharma and Athenex Pharmaceutical Division Announce Busulfan Injection Product Launch,GlobeNewswire
Mar-14-19,Edited Transcript of ATNX earnings conference call or presentation 11-Mar-19 12:30pm GMT,Thomson Reuters StreetEvents
Mar-15-19,"Athenex Inc (ATNX) CEO and Chairman of the Board Johnson Yiu Nam Lau Bought $141,240 of Shares",GuruFocus.com
Mar-19-19,"Athenex Inc (ATNX) CEO and Chairman of the Board Johnson Yiu Nam Lau Bought $226,212 of Shares",GuruFocus.com
Mar-21-19,Athenex Announces Xiangxue Life Sciences Receives IND Allowance from Chinas National Medical Products Administration for Cancer Immunotherapy Drug Candidate,GlobeNewswire
Mar-21-19,Athenex Announces Expansion of Board of Directors,GlobeNewswire
Mar-25-19,"Athenex Inc (ATNX) CEO and Chairman of the Board Johnson Yiu Nam Lau Bought $124,500 of Shares",GuruFocus.com
Mar-26-19,"New Research Coverage Highlights UnitedHealth Group, Ultragenyx Pharmaceutical, Navistar International, REGENXBIO, Par Pacific, and Athenex  Consolidated Revenues, Company Growth, and Expectations for 2019",GlobeNewswire
Mar-27-19,"Athenex Inc (ATNX) CEO and Chairman of the Board Johnson Yiu Nam Lau Bought $124,000 of Shares",GuruFocus.com
Mar-28-19,Athenex Announces Appointment of Dr. Daniel Von Hoff as Chairman of the Scientific Advisory Board of Axis Therapeutics Limited,GlobeNewswire
Mar-29-19,Athenex Announces Appointment of Jordan S. Kanfer to Board of Directors,GlobeNewswire
Mar-29-19,"Athenex Inc (ATNX) CEO and Chairman of the Board Johnson Yiu Nam Lau Bought $124,000 of Shares",GuruFocus.com
Apr-01-19,Weekly CEO Buys Highlight,GuruFocus.com
Apr-02-19,Athenex Announces Appointment of John Koh as a New Board Member,GlobeNewswire
Apr-23-19,Athenex Announces Abstracts Accepted for Presentation at the 2019 American Society of Clinical Oncology Annual Meeting,GlobeNewswire
Apr-25-19,"Athenex, Inc. to Report First Quarter 2019 Earnings Results on May 9, 2019",GlobeNewswire
May-03-19,Athenex Announces Promising Early and Complete Response Data from a Clinical Study of Oraxol in Cutaneous Angiosarcoma,GlobeNewswire
May-06-19,"Why Bausch Health Companies, Aquantia, and Athenex Jumped Today",Motley Fool
May-06-19,Athenex just raised $100 million. Here's what it means,American City Business Journals
May-06-19,Athenex Announces $100 Million Private Placement,GlobeNewswire
